A phase II, randomised, non-comparative two-arm trial of neoadjuvant chemotherapy plus either olaparib or olaparib + durvalumab in young, pre-menopausal women with HR-positive, HER2-negative early breast cancer (BCT 2301 OLIO).
收藏DataCite Commons2025-12-10 更新2024-07-13 收录
下载链接：
https://doi.breastcancertrials.org.au/112
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
HeSANDA 1.0.0
提供机构：
Breast Cancer Trials (BCT)
创建时间：
2024-07-09
